APA (7th ed.) Citation

ER, G., S, T., BA, L., MH, T., O, A., MA, P., . . . LJ, G. (2025). Romidepsin and mogamulizumab sequential treatment for advanced cutaneous T-cell lymphoma. Leukemia & lymphoma, 66(12), 2277. https://doi.org/10.1080/10428194.2025.2542941

Chicago Style (17th ed.) Citation

ER, Gordon, et al. "Romidepsin and Mogamulizumab Sequential Treatment for Advanced Cutaneous T-cell Lymphoma." Leukemia & Lymphoma 66, no. 12 (2025): 2277. https://doi.org/10.1080/10428194.2025.2542941.

MLA (9th ed.) Citation

ER, Gordon, et al. "Romidepsin and Mogamulizumab Sequential Treatment for Advanced Cutaneous T-cell Lymphoma." Leukemia & Lymphoma, vol. 66, no. 12, 2025, p. 2277, https://doi.org/10.1080/10428194.2025.2542941.

Warning: These citations may not always be 100% accurate.